Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.890
+0.080 (4.42%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $49.67 million as of October 9, 2026. It is the 30,507th most valuable company in the world and the 4,681st biggest in the United States. Its market cap has decreased by 71.07% in one year.
Market Cap
49.67M
Enterprise Value
40.34M
1-Year Change
-71.07%
Global Rank
Country Rank
#4,681 United States
Category
ChartMarket Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $49.67M, a decrease of -84.09%. That is a compound annual growth rate of -42.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 49.67M | -64.29% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 51.19M |
| Annovis Bio | 49.85M |
| CervoMed | 49.44M |
| Edesa Biotech | 49.21M |
| Dogwood Therapeutics | 48.95M |
| eXoZymes | 48.91M |
| BioStem Technologies | 48.69M |
| ImageneBio | 47.79M |